ADME Toxicology Testing Market Size, Share, Growth, Global Trends, and Report 2022-2027
The latest report by IMARC Group, titled “ADME Toxicology Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the global ADME toxicology testing market. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global ADME toxicology testing market size reached US$ 7.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 15.5 Billion by 2027, exhibiting a growth rate (CAGR) of 13.73% during 2022-2027.
ADME toxicology refers to the testing of absorption, distribution, metabolism, and excretion (ADME) conducted at an early phase of the drug development process. It determines the safety, elimination, uptake, effectiveness, and metabolic behavior of a parent compound or drug in living organisms. ADME toxicology is primarily carried out by researchers in cell-based and in vitro assays using detectors, software solutions, devices, etc. It identifies genetic interactions, active compounds, and other biomolecular interactions. This type of testing aids in understanding the toxicity of a drug candidate before clinical studies, thereby saving drug discovery time and costs.
Note: We are updating our reports, If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.
Request Free Sample Report: https://www.imarcgroup.com/adme-toxicology-testing-market/requestsample
Market Trends:
The rising prevalence of chronic diseases has increased the need for novel biological products and other drugs, thereby primarily driving the ADME toxicology testing market. The testing aids researchers in determining the viability of the drugs required for regulatory approvals. Furthermore, the emergence of new guidance norms to instruct about the properties of ADME when evaluating the safety and efficacy of a drug candidate also augments the market growth. Additionally, the introduction of innovative software that automatically calculates ADME is also gaining traction for several in-vivo experiments and in-vitro assays. This is further expected to drive the global market for ADME toxicology testing market in the coming years.
Explore the Full Report with TOC & List of Figures: https://www.imarcgroup.com/adme-toxicology-testing-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.
Some of these key players include:
- Agilent Technologies Inc.
- Beckman Coulter Inc. (Danaher Corporation)
- Bioivt LLC
- Bio-Rad Laboratories Inc.
- Charles River Laboratories International Inc.
- Cyprotex Plc (Evotec AG)
- Molecular Discovery Ltd.
- Perkinelmer Inc.
- Promega Corporation
- Thermo Fisher Scientific Inc
Key Market Segmentation:
Breakup by Technology:
- Cell Culture
- High Throughput Screening
- Molecular Imaging
- OMICS Technology
- Others
Breakup by Product Type:
- Instruments
- Software Solutions
- Assay Systems
- Reagents
- Others
Breakup by Method:
- In-Vivo
- In-Vitro
- In-Silica
- Others
Breakup by Application:
- Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Key highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Latest Research Reports by IMARC Group:
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
